Profusa Stock Spikes As Lumee System Targets Research Market

Benzinga_recent_news01-17

Profusa, Inc. (NASDAQ:PFSA) stock rallied on Friday as the company is launching its Healthcare Research version of the Lumee tissue oxygen monitoring system. The stock is trading with a massive volume...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2604491330?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/16/Medical-Professionals-In-Research-And-De.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-01-17 01:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604491330","market":"sh","top_or_hot":-1,"title":"Profusa Stock Spikes As Lumee System Targets Research Market","media":"Benzinga_recent_news","content":"<div>\n<p>Profusa, Inc. (NASDAQ:PFSA) stock rallied on Friday as the company is launching its Healthcare Research version of the Lumee tissue oxygen monitoring system.\nThe stock is trading with a massive volume...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/01/49973068/profusa-stock-spikes-as-lumee-system-targets-research-market\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Profusa Stock Spikes As Lumee System Targets Research Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProfusa Stock Spikes As Lumee System Targets Research Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-17 01:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/health-care/26/01/49973068/profusa-stock-spikes-as-lumee-system-targets-research-market><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Profusa, Inc. (NASDAQ:PFSA) stock rallied on Friday as the company is launching its Healthcare Research version of the Lumee tissue oxygen monitoring system.\nThe stock is trading with a massive volume...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/01/49973068/profusa-stock-spikes-as-lumee-system-targets-research-market\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.benzinga.com/news/health-care/26/01/49973068/profusa-stock-spikes-as-lumee-system-targets-research-market","article_id":"2604491330","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/16/Medical-Professionals-In-Research-And-De.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/49973068/profusa-stock-spikes-as-lumee-system-targets-research-market","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2604491330","pubTimestamp":1768585860,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Profusa shares surged on heavy volume after launching its Lumee tissue oxygen monitoring system for research use, targeting contract research organizations and near-term service revenue.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK4217":"自存仓储房地产信托","PFSA":"Profusa Inc","SMA":"Smartstop Self Storage REIT Inc"},"translate_title":"Lumee System瞄准研究市场，Profusa股价飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFSA":1,"SMA":1},"content_text":"Profusa, Inc. (NASDAQ:PFSA) stock rallied on Friday as the company is launching its Healthcare Research version of the Lumee tissue oxygen monitoring system.\nThe stock is trading with a massive volume of 140.93 million versus the average volume of 25.7 million, according to Benzinga Pro data.\nThe company announced that its Lumee tissue oxygen products are now commercially available for contract research organizations (CROs), targeting a market projected to grow from approximately $47.9 billion in 2025 to over $91.2 billion by 2034 at a CAGR of more than 7%.\nThis strategic move is expected to generate immediate service-based revenue and enhance drug development efficiency by providing real-time biological data.\nProfusa’s Lumee tissue oxygen system will be offered as research-use-only kits, allowing CRO partners to incorporate the technology into existing study designs with minimal implementation risk.\nThis provides researchers and R&D teams access to continuous, real-time measurement of tissue oxygenation, providing critical insights across a range of applications, including advanced in vitro and organ-on-chip models, preclinical pharmacology and toxicology studies, and translational research programs.\nThe company has appointed Sean Givens to lead commercialization efforts, emphasizing the strong interest in their validated sensors across the industry.\nThe stock is currently trading 21.2% above its 20-day simple moving average (SMA) but is 51.3% below its 100-day SMA, indicating a short-term bullish trend while struggling in the longer term. Shares have decreased 94.35% over the past 12 months and are currently positioned closer to their 52-week lows than highs.\nThe RSI is at 44.33, which is considered neutral territory, suggesting that there is no immediate overbought or oversold condition. Meanwhile, MACD is above its signal line, indicating a bullish momentum that could support further price increases.\nThe combination of neutral RSI and bullish MACD suggests mixed momentum, which may lead to cautious optimism among traders.\nPFSA Price Action: Profusa stock is up 20.30% at $0.12 at the time of publication on Friday, according to Benzinga Pro data.\nPhoto: Gorodenkoff via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2604491330","isCrawlerRequest":true}